HR 8641 · 117th Congress
Orphan Drug COVID–19 Mitigation Act of 2022
<p><b>Orphan Drug COVID-19 Mitigation Act of 2022</b></p> <p>This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period. </p>
- Introduced
- 2022-08-02
- Policy area
- Health
- Latest action
- Referred to the House Committee on Energy and Commerce.
Digging through Congress... 🔍